Natural Product Chemistry for Drug Discovery

Author:   Antony D Buss (MerLion Pharmaceuticals, Singapore) ,  Mark S Butler (The University of Queensland, Australia) ,  Sheo Singh ,  Barbara Potts
Publisher:   Royal Society of Chemistry
Volume:   Volume 18
ISBN:  

9780854041930


Pages:   458
Publication Date:   21 October 2009
Format:   Hardback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $375.16 Quantity:  
Add to Cart

Share |

Natural Product Chemistry for Drug Discovery


Add your own review!

Overview

Natural Product Chemistry for Drug Discovery provides a comprehensive summary of where natural product chemistry is today in drug discovery. The book covers emerging technologies and case studies and is a source of up-to-date information on the topical subject of natural products. Natural products are once again considered important tools in the drug discovery toolbox. The authors are all experts in their respective fields of natural product chemistry. The book will appeal across the board from scientists to professionals, postgraduates and industrial chemists. The case studies selected for inclusion highlight recently marketed drugs and development candidates that have been derived from natural products. These 'real-life' examples show how new technologies, such as advances in screening, isolation, dereplication and prefractionation, have significantly enhanced the discovery process.

Full Product Details

Author:   Antony D Buss (MerLion Pharmaceuticals, Singapore) ,  Mark S Butler (The University of Queensland, Australia) ,  Sheo Singh ,  Barbara Potts
Publisher:   Royal Society of Chemistry
Imprint:   Royal Society of Chemistry
Volume:   Volume 18
Dimensions:   Width: 15.60cm , Height: 3.30cm , Length: 23.40cm
Weight:   2.363kg
ISBN:  

9780854041930


ISBN 10:   0854041931
Pages:   458
Publication Date:   21 October 2009
Audience:   College/higher education ,  Professional and scholarly ,  Postgraduate, Research & Scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Chapter 1: Natural Products as Drugs and Leads to Drugs: the Historical Perspective; Chapter 2: Chemical Space and the Difference between Natural Products and Synthetics; Chapter 3: The Importance of Mechanism of Action Studies; Chapter 4: The Convention on Biological Diversity and its Impact on Natural Product Research; Chapter 5: Plants: Revamping the Oldest Source of Medicines with Modern Science; Chapter 6: Macromarines: a Selective Account on the Potential of Marine Sponges, Molluscs, Soft Corals and Tunicates as a Source of Therapeutically Important Molecular Structures; Chapter 7: Microorganisms: their Role in the Discovery and Development of Medicines; Chapter 8: Advances in Biological Screening for Lead Discovery; Chapter 9: Advances in Instrumentation and Automation, Dereplication and Prefractionation; Chapter 10: Natural Product Combinatorial Biosynthesis: Promises and Realities; Chapter 11: A Snapshot of Natural Product-Derived Compounds in Late Stage Clinical Development at the End of 2008; Chapter 12: From Natural Product to Clinical Trials: NPI-0052 (Salinosporamide A), a Marine Actinomycete-Derived Anticancer Agent; Chapter 13: From Natural Product to Clinical Trials: Bevirimat, a Plant-Derived Anti-AIDS Drug; Chapter 14: Daptomycin; Chapter 15: Micafungin; Chapter 16: From rapamycin to temsirolimus;

Reviews

This volume serves as a useful reminder that even as the first decade of the 21st century comes to a close, natural products are still a valuable resource for the new therapeutic agents and new drug leads with broad structural diversity. This is a timely and highly informative text that belongs in institutional libraries where biomedical research is carried out...many natural product researchers, as well as medicinal chemists, synthetic organic chemists, and pharmacologists will find this volume well worthy of purchase for their personal libraries. Journal of Medicinal Chemistry, 2010, 53 P2329


This volume serves as a useful reminder that even as the first decade of the 21st century comes to a close, natural products are still a valuable resource for the new therapeutic agents and new drug leads with broad structural diversity. This is a timely and highly informative text that belongs in institutional libraries where biomedical research is carried out...many natural product researchers, as well as medicinal chemists, synthetic organic chemists, and pharmacologists will find this volume well worthy of purchase for their personal libraries. -- Journal of Medicinal Chemistry, 2010, 53 P2329 Journal of Medicinal Chemistry


Author Information

Dr A.D. Buss graduated from the Royal Institute of Chemistry before receiving his MSc from the University of East Anglia and then a PhD from the University of Cambridge. He started his career in the pharmaceutical industry with Pfizer before moving to Schering Agrochemicals as a Team Leader. In 1989, he joined Glaxo as Research Manager prior to becoming Head of the Natural Products Discovery Department and, finally, Research Unit Head, Bioprocessing, in 1995. During this period, Dr. Buss served as Chairman of the GlaxoWellcome (UK) Research Management Team and Chairman of the Joint Project Team (combinatorial polyketide biosynthesis) for what was GlaxoWellcome's largest research collaboration with the University of Cambridge. In 2000, he became head of the Centre for Natural Product Research at the Institute of Molecular and Cell Biology in Singapore and, on the Centre's privatisation to MerLion Pharmaceuticals in May 2002, became its President and Chief Executive Officer. Dr Buss is the author or co-author of over fifty peer reviewed scientific publications. Dr Mark S. Butler received his BSc (Hons) and PhD from The University of Melbourne. After postdoctoral work at the Arizona State University, he joined the Queensland Pharmaceutical Research Institute (now Natural Product Research). He then moved to Singapore to lead the Natural Product Chemistry group at the Centre of Natural Product Research (CNPR), which was part of the Institute of Molecular and Cell Biology (IMCB). In 2002, CNPR privatized to become MerLion Pharmaceuticals where his present position is Director of Natural Product Chemistry. He has contributed to over 40 papers on various aspects of natural products chemistry and, in 2002, was awarded the Matt Suffness (Young Investigator) Award by the American Society of Pharmacognosy. His research interests include isolation, structure elucidation, absolute configuration and mechanism of natural products and development of natural product leads into pharmaceuticals, as well as separation of compounds using liquid-liquid chromatography and large-scale isolation of natural products.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

JRG25

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List